Mar 26, 2014 by Dan CarrollDisney Takes a Hit Behind the Dow's Hundred-Point DropDirecTV and Dish Network shake up the market as rumors emerge about the possibility of a merger between the two satellite TV behemoths
Mar 26, 2014 by Dan CarrollWhile the Dow Drops, Pfizer Leads Big Pharma's Great DayJohnson & Johnson also hits the high marks today as health care puts in a solid outing for investors
Mar 25, 2014 by Dan CarrollCisco, Big Pharma Lead the Dow's PopMarkets have a big day as consumer confidence data surprises.
Mar 24, 2014 by Dan CarrollWill This Stock Rule the Next Generation of Cholesterol Medicine?Amgen's fired on all cylinders in 2014 as up-and-coming PCSK9 inhibitor evolocumab has hit its targets in trial after trial. Can it beat stiff competition to become this big biotech's next blockbuster?
Mar 24, 2014 by Dan CarrollDiving Pharmas Merck and Pfizer Drop the DowA health-care sell-off around the market hampers the Dow on an up-and-down day.
Mar 21, 2014 by Dan CarrollSt. Jude Sparks Hope for a Pain-Free FutureSt. Jude's struggling against rivals Medtronic and Boston Scientific in the neuromodulation space, but its latest approval of its Prodigy device should keep investors looking for more.
Mar 21, 2014 by Dan CarrollDow Plunges Into the Red Amid Nike's Earnings Fallout Symantec makes the big splash of the day with its unexpected firing of CEO Steve Bennett.
Mar 21, 2014 by Dan CarrollCan These Companies Bounce Back from Disappointing Sales?Promising blood thinner Eliquis hasn't quite lived up to the hype surrounding it in its early life. Can Pfizer and Bristol-Myers Squibb turn things around?
Mar 20, 2014 by Dan CarrollJPMorgan Leads the Dow's Triple-Digit RiseNike slumps ahead of its earnings release despite the Dow's big climb.
Mar 20, 2014 by Dan CarrollBad News Buy: Intuitive Surgical vs. Edwards LifesciencesInnovative medical device stocks Intuitive Surgical and Edwards Lifesciences have been hit hard over the past year, but is either stock an under-the-radar pick ready to bounce back?
Mar 20, 2014 by Dan CarrollObamacare's Medicaid Expansion Could Mean a Windfall for These 3 StocksThe Affordable Care Act's state-by-state Medicaid expansion has added millions of new Medicaid customers, and the future could be even brighter for top Medicaid players such as Centene and WellPoint
Mar 19, 2014 by Dan CarrollObamacare's 5 Million Mark Can't Hold Back the Dow's DropThe Fed's latest minutes sink the Dow in the afternoon despite UnitedHealth's good day.
Mar 18, 2014 by Dan CarrollMicrosoft Powers the Dow's Triple-Digit JumpGameStop shares slump following a big announcement from Wal-Mart.
Mar 17, 2014 by Dan CarrollTriple-Digit Dow Jones Rise Can't Do Much for Home DepotCaterpillar gains 0.4% after strong manufacturing data.
Mar 14, 2014 by Dan CarrollBoeing Flies High, but the Dow Can't Escape the RedGE and other leading blue-chip stocks fall to keep the Dow down for the day.
Mar 13, 2014 by Dan CarrollPfizer Tumbles Beside a Triple-Digit Plunge for the DowUnited Technologies also falls sharply on a downbeat day for stocks across the markets.
Mar 13, 2014 by Dan CarrollBetter Dividend: GlaxoSmithKline vs. AbbVieTwo of big pharma's best stocks offer high-yielding dividends, but is GlaxoSmithKline or AbbVie better for your long-term portfolio?
Mar 12, 2014 by Dan CarrollChevron Rises Despite the Dow's StrugglesIt's been a down day for stocks despite gains from Chevron and AT&T on the Dow
Mar 12, 2014 by Dan CarrollBetter Biotech Buy: Alexion Pharmaceuticals, Inc. vs. RegeneronTwo big biotech stocks have captured investor attention for their impressive growth over the past year, but is Alexion or Regeneron more likely to keep up the momentum in the future?
Mar 11, 2014 by Dan CarrollMcDonald's Rallies, but DuPont Leads the Dow Into the RedStocks fall despite a strong day from McDonald's, while an upgrade helps J.C. Penney soar
